Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: A randomised trial

Lancet

Volumn 359, Issue 9312, 2002, Pages 1108-1113

  Fang, James C ^a   Kinlay, Scott ^a   Beltrame, John ^a   Hikiti, Hiroyuki ^a   Wainstein, Marco ^a   Behrendt, Dominik ^a   Suh, Jung ^b   Frei, Balz ^b   Mudge, Gilbert H ^a   Selwyn, Andrew P ^a   Ganz, Peter ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; PRAVASTATIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE COURSE; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; ENDOTHELIUM; FEMALE; FOLLOW UP; HEART TRANSPLANTATION; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0037197039     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)08154-0     Document Type: Article

References (34)

1. Intravascular ultrasound imaging after cardiac transplantation: Advantage of multi-vessel imaging
2. The pathogenesis of coronary arteriosclerosis ("chronic rejection") in transplanted hearts
3. Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant
4. Effect of pravastatin on outcomes after cardiac transplantation
5. Simvastatin reduces graft vessel disease and mortality after heart transplantation: A four-year randomized trial
6. The regulation and roles of Rel/NF-kappa B transcription factors during lymphocyte activation
7. Glucocorticoid-mediated gene suppression of rat cytokine-induced neutrophil chemoattractant CINC/gro, a member of the interleukin-8 family, through impairment of NF-kappa B activation
8. NAD(P)H oxidase: Role in cardiovascular biology and disease
9. Ascorbic acid and alpha-tocopherol prolong rat cardiac allograft survival
10. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes
11. CD40 and CD40 ligand (CD154) are coexpressed on microvessels in vivo in human cardiac allograft rejection
12. Endomyocardial biopsy diagnosis of acute rejection in cardiac allografts
13. Relation of preservation of nitric oxide-dependent coronary vasomotor function to plasma vitamin C concentrations in cardiac transplant recipients
14. Plasma alpha-tocopherol and coronary endothelium-dependent vasodilator function
15. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries
16. Responses of coronary arteries of cardiac transplant patients to acetylcholine
17. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion
18. Functional significance of intimal thickening as detected by intravascular ultrasound early and late after cardiac transplantation
19. Longitudinal study of vascular remodeling in coronary arteries after heart transplantation
20. Intravascular ultrasound: Novel pathophysiological insights and current clinical applications
21. Physiology of reactive oxidant-mediated signal transduction: An overview
22. Atherosclerosis as disease of redox-sensitive genes
23. Oxidative stress as a regulator of gene expression in the vasculature
24. Compromised antioxidant status and persistent oxidative stress in lung transplant recipients
25. Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease
26. Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts
27. Vitamin E supplementation and cardiovascular events in high-risk patients
28. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial
29. Potential antiatherogenic mechanisms of ascorbate (Vitamin C) and alpha-tocopherol (Vitamin E)
30. Loss of the coronary microvascular response to acetylcholine in cardiac transplant patients
31. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress
32. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes
33. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia
34. Incidence and progression of transplant coronary artery disease over 1 year: Results of a multicenter trail and use of intravascular ultrasound